ST6GALNAC1 and gastric cancer: The two selected cell lines to test our method were derived from the gastric cancer cell line MKN45: HST6, which was genetically modified to present truncated O-glycans at their surface, due to the over-expression of the ST6GalNAc1 sialyltransferase - and Mock - the corresponding control cells transfected with the empty vector19.